Tag Archives: copd

Details about The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD

The clinical characteristics of the 365 patients studied are shown in Table 1. As expected, the patients had important airflow limitation, were mostly men, and the group included patients with a wide range of COPD severity. There were 171 deaths … Continue reading

Research of The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD

Patients The 365 consecutive patients with symptomatic COPD had been recruited to the body-mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) protocol at the Bay Pines Veterans Administration Health Care System (n = 278) and St. Elizabeth’s Medical Center … Continue reading

My Canadian Pharmacy: The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD

There has been great interest in evaluating the role of exercise testing in patients with COPD. Exercise testing is used to explore the mechanisms of dyspnea and its response to treatment. In addition, the maximal oxygen uptake (Vo2) measured at … Continue reading

Canadian Neighbor Pharmacy: Disscusion of Oxygen Supplemented Exercise of Ventilatory and Nonventilatory Muscles in Pulmonary Rehabilitation

The use of inspiratory muscle resistive loading training plus nonventilatory muscle exercise (particularly walking) while breathing oxygen improves exercise performance and endurance in COPD patients during ten-week outpatient therapy.

Skin Manifestations of Inhaled Corticosteroids in COPD Patients: The effect of compliance

In the present report, easy bruising averaged 7.6% in the ICS group and 3.6% in the placebo group among all participants. These findings are roughly similar to those reported from previously published randomized controlled trials of ICS in COPD pa-tients, … Continue reading

Skin Manifestations of Inhaled Corticosteroids in COPD Patients: ICS therapy

Weaknesses of the above-cited older studies are that they were cross-sectional, nonrandomized surveys and that they relied on retrospective reporting of previous, as well as current, ICS use. Moreover, some subjects had received oral corticosteroids in variable amounts at least … Continue reading

Skin Manifestations of Inhaled Corticosteroids in COPD Patients: CFC

The relevance of these findings to potential cutaneous effects of other commonly used ICSs might be inferred from published data concerning the equi-systemic effects (ie, microgram dose producing equal systemic cortisol suppression) of six inhaled corticosteroid preparations. According to the … Continue reading

Skin Manifestations of Inhaled Corticosteroids in COPD Patients: Discussion

Easy Bruising and Acetylsalicylic Acid/Nonsteroidal Anti-inflammatory Drug Use Use of acetylsalicylic acid (ASA) or nonsteroidal anti-inflammatory drugs (NSAIDs) was reported by a slightly but significantly higher proportion of participants who also reported bruising (87.7%) than those who did not (78.8%; … Continue reading

Skin Manifestations of Inhaled Corticosteroids in COPD Patients: Slow Healing

Table 5 shows the results from logistic regression of reports of slow healing of any severity. The results indicate a significant treatment effect, mainly among the good compliers. Older age is also a significant predictor in all participants with a … Continue reading

Skin Manifestations of Inhaled Corticosteroids in COPD Patients: The ICS group

The percentages of participants reporting bruises a 25% of the time are shown in Figure 2. Again, clear and significant (p < 0.05) differences are found between the good compliers in the ICS group and all of the other subgroups, … Continue reading

Pages: 1 2 3 4 5 Next